Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Parallels in Pathogenesis and Treatment
Authors:
- 12 May 2023
- journal article
- review article
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 23 (6) , 341-350
Abstract
Purpose of Review Since it first appeared, multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has been compared to Kawasaki disease (KD). Although there were early parallels between MIS-C and KD, key differences emerged over time. Here, we aim to compare the pathogenesis, clinical presentation, treatment, and outcomes of MIS-C and KD. Recent Findings In this article, we review and compare MIS-C and KD, highlighting differentiating features. We discuss the epidemiological and immunological factors along with clinical and laboratory features which discern MIS-C from KD. We also compare treatment and our understanding of long-term outcomes. Summary Though parallels exist between MIS-C and KD, distinguishing the two is important for clinical management of patients, counseling about natural history, and determining long-term monitoring. While both MIS-C and KD are characterized by profound inflammation and inflammatory vasculopathy, further study is needed to determine whether they are distinct immunopathogenic disorders.Keywords
Funding Information
- National Center for Advancing Translational Sciences (KL2TR002490)
This publication has 62 references indexed in Scilit:
- Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican childrenEuropean Journal of Pediatrics, 2012
- Kawasaki disease: update on pathogenesisCurrent Opinion in Rheumatology, 2010
- The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki diseaseClinical and Experimental Immunology, 2010
- Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007The Pediatric Infectious Disease Journal, 2010
- Associated Symptoms in the Ten Days Before Diagnosis of Kawasaki DiseaseThe Journal of Pediatrics, 2009
- ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysmsNature Genetics, 2007
- Prevention of Infective EndocarditisCirculation, 2007
- Diffuse alveolar hemorrhage syndromes in childrenCurrent Opinion in Pediatrics, 2007
- Elevated Levels of Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 during the Acute Phase of Kawasaki DiseaseClinical and Vaccine Immunology, 2003
- Outcome of coronary artery aneurysms after Kawasaki diseaseThe Journal of Pediatrics, 1992